Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
27.43
-0.92 (-3.25%)
Aug 5, 2026, 12:26 PM EDT - Market open
Beam Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 156.04 | 139.74 | 63.52 | 377.71 | 60.92 | 51.84 | |
Revenue Growth | 158.89% | 120.01% | -83.18% | 520.01% | 17.51% | 215916.67% |
Gross Profit | 156.04 | 139.74 | 63.52 | 377.71 | 60.92 | 51.84 |
Selling, General & Admin | 125.4 | 113.82 | 111.53 | 116.81 | 87.81 | 57.22 |
Research & Development | 408.66 | 409.62 | 367.56 | 437.38 | 311.59 | 387.09 |
Total Operating Expenses | 534.06 | 523.44 | 479.09 | 554.19 | 399.4 | 444.31 |
Operating Income | -378.02 | -383.69 | -415.57 | -176.49 | -338.48 | -392.47 |
Interest Income | 38.9 | 43.73 | 49.09 | 46.68 | 15.3 | -0.01 |
Other Non-Operating Income (Expense) | -1.9 | 259.97 | -10.23 | -1.35 | 37.5 | 21.84 |
Total Non-Operating Income (Expense) | 37 | 303.7 | 38.87 | 45.32 | 52.8 | 21.83 |
Pretax Income | -341.03 | -79.99 | -376.7 | -131.16 | -260.18 | -370.64 |
Provision for Income Taxes | - | - | -0.04 | -1.37 | -3.41 | - |
Net Income | -85.43 | -79.99 | -376.74 | -132.53 | -289.09 | -370.64 |
Net Income to Common | -85.43 | -79.99 | -376.74 | -132.53 | -289.09 | -370.64 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 103 | 99 | 82 | 77 | 70 | 64 |
Shares Outstanding (Diluted) | 104 | 99 | 82 | 77 | 70 | 64 |
Shares Change | 16.86% | 20.16% | 6.69% | 10.19% | 9.01% | 37.44% |
EPS (Basic) | -0.82 | -0.81 | -4.58 | -1.72 | -4.13 | -5.77 |
EPS (Diluted) | -0.86 | -0.81 | -4.58 | -1.72 | -4.13 | -5.77 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -372.77 | -360.05 | -356.19 | -182.93 | -26.42 | -113.08 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -3.59 | -3.64 | -4.33 | -2.37 | -0.38 | -1.76 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -242.27% | -274.57% | -654.25% | -46.73% | -555.61% | -757.01% |
Profit Margin | -54.75% | -57.24% | -593.13% | -35.09% | -474.54% | -714.91% |
FCF Margin | -238.90% | -257.65% | -560.77% | -48.43% | -43.37% | -218.11% |
EBITDA | -355.78 | -361.4 | -393.64 | -156.47 | -324.33 | -385.01 |
EBITDA Margin | -228.01% | -258.62% | -619.74% | -41.43% | -532.39% | -742.64% |
EBIT | -378.02 | -383.69 | -415.57 | -176.49 | -338.48 | -392.47 |
EBIT Margin | -242.27% | -274.57% | -654.25% | -46.73% | -555.61% | -757.01% |
Effective Tax Rate | - | 0.00% | 0.01% | 1.04% | 1.31% | 0.00% |